Charles Bancroft who is Executive Vice President and Head of Integration, will become Non-Executive Director on May 1, 2020 (news posted on March 23 2020).
Elizabeth Mily will join the company as Executive Vice President, Strategy and Business Development on Mar. 30, 2020 (news posted on March 18 2020).
Michael Quigley, Vice President and Head of Oncology Discovery Biology and Site Head, Redwood Cit, has left the company (news posted on February 19 2020).
Create an alert
to follow the executive moves at Bristol-Myers Squibb.
La Jolla Pharmaceutical has announced the acquisition of Tetraphase Pharmaceuticals (posted on Jun 24, 2020).
Melinta Therapeutics has announced the acquisition of Tetraphase Pharmaceuticals (posted on Jun 5, 2020).
Change Healthcare has announced the acquisition of PDX (posted on Jun 1, 2020).
Bristol-Myers Squibb has 22 subsidiaries including Bristol Myers Squibb Russia, Bristol-Myers Squibb APAC and Bristol-Myers Squibb Australia. Bristol-Myers Squibb has 2,010 competitors including Johnson & Johnson (United States (USA)), Sanofi (France) and Roche (Switzerland).
Learn about your clients' org charts. Understand their industries and their competitors.
View the executives' biographies. Contact the executives through our email platform.
Select key words to follow your clients. Receive alerts when executive movements happen.
File your clients in folders. Add private notes. Download our data in Excel on your PC.